of the author and do not reflect the official views of the US Army, the US Department of Defense, or the US Government. I have no financial conflict
|
|
- Leonard Glenn
- 6 years ago
- Views:
Transcription
1 Role for Militaries i in the New Era of Malaria Elimination and Eradication APMMC 2009 Colin Ohrt, MD, MPH; COL, MC Consultant to the Surgeon General for Clinical Pharmacology Chief, Department of Clinical Pharmacology & Translational Medicine Division of Experimental Therapeutics Walter Reed Army Institute of Research 1
2 Disclaimer The opinions presented in this lecture are those of the author and do not reflect the official views of the US Army, the US Department of Defense, or the US Government. I have no financial conflict of interests to declare Off label use of FDA approved drugs will be discussed with primaquine. 2
3 Agenda Current plans for malaria elimination in Asia How militaries have assisted in the past Indentify partnerships Research studies Elimination operations Vision for the future 3
4 Malaria: Scope of Disease 270 million cases annually 1-2 million people die Significant morbidity Those at risk 2 billion worldwide Travelers Deployed troops 4
5 Bill & Melinda Gates Foundation. Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication. (2007). New Era Bill and Melinda Gates Call for New Global l Commitment to Chart a Course for Malaria Eradication * *Bill & Melinda Gates Foundation (2007). 5
6 Roll Back Malaria Partnership launched in 1998 (WHO, UNICEF, UNDP & World Bank) Wide range of partners (not military) Vision = 2015 the malaria-related Millennium Development Goals (MDGs) achieved. malaria is no longer a major cause of mortality no longer a barrier to social and economic development Mission work together sustained delivery and use of the most effective prevention and treatment 6
7 Asia Pacific Malaria Elimination Network Recently established Led by Sir Richard UCSF Objectives Bring together: 10 eliminating countries in the Region multilateral and academic agencies Provide: leadership, advocacy, capacity building, information sharing, building of the evidence base 7
8 Key APMEN Activities Annual meetings with additional working groups Review and document country experiences Support catalytic operational research projects Develop evidence-based recommendations Establish an information hub Capacity building APMEN fellows program Training modules Special focus on P. vivax Info: 8
9 Initial Asian Countries Planned for Elimination 9
10 Western Cambodia Elimination Goal: Artemisinin resistance containment Will be challenging Multidrug-resistance Effective Rx Access Adherence Community acceptance Mass drug administration i ti Mosquito control Accurate diagnosis Migrant management Soldier management Vendor drug control Counterfeits Ineffective regimens Slide 10
11 Malaria History: World War II Sicilian campaign 21,000 malaria admissions 17,000 battle casualties Pacific theater 40% incapacitation due to malaria Guadalcanal & PNG - 5 fold more Lost time 2-3 weeks per person
12 Operational Evaluation of JTF- Liberia 80 of 220 marines contracted falciparum malaria. 46 required medical evacuation 5/80 (6.25%) were severe Requiring ICU admissions Four on ventilators Key problems: Non-compliance Inability to make the diagnosis 12 They were all given their medication (Lariam), we are investigating why do we have all these guys (Marines in Liberia) coming down with this.bbc News September 10, 2003
13 13
14 14
15 Why Do We Need More Antimalarials? Global drug resistance. Useful lifespan of a new drug is yrs Will likely lose all current drugs before eradication Malarone is a particular problem Substantial toxicities Lariam psychosis G6PD-deficiency GI tolerability Malarone 15
16 4 Species P. Falciparum P. Vivax P. Ovale P. Malaria Transmission -blocking DEET Bed nets ITN Screening Suppressive Prophylaxis & Treatment Causal Prophylaxis Radical Cure (PV/PO) 16
17 Indications for Antimalarial Drugs Prophylaxis Causal prophylaxis Suppressive prophylaxis Intermittent presumptive treatment Treatment of Disease Uncomplicated malaria P. falciparum P. vivax/p. ovale Severe and complicated malaria Antihypnozoite (radical cure) Transmission Blocking 17
18 FDA Approved Products from the US Army for Malaria Chloroquine-Primaquine CP tabs Mefloquine Lariam Halofantrine Halfan Doxycycline Vibramycin Atovaquone/Proguanil Malarone Malaria RDT BinaxNow Malaria G6PD-deficiency RDT BinaxNow G6PD 18
19 Antimalarial Products in Development from the US DoD D Vaccines RTSS vaccine Whole sporozoite vaccine Diagnostics 4 efforts to get more sensitive methods Validated samples Drugs IV Artesunate Weekly atovaquone-proguanil (Malarone ) Azithromycin combinations Tafenoquine 19
20 Prophylaxis Drugs in Malaria a a Elimination Needed properties Used successfully on Aneityum island Residual foci (transmission reservoir) Epidemic control Bring down high level transmission Endorsed by malera (Gates research planning group) Pharmaceutical company leadership 20
21 21
22 Military Contribution Not spread malaria Malaria diagnostics Clinical trials for product approval Support of elimination operations 22
23 Not Spread Malaria - Examples % Gametocyte Carriage in Thai troops during elimination in Eastern Thailand 70% CH n=150 60% TQH 50% n=274 40% QD n=85 On Admission At Any Time 30% 20% 10% HE n=59 SA n=40 0% Years, Study Code, and Number of Participants 23
24 Not Spread Malaria - Examples South Korean troops P. vivax Eliminated in 1970 s Returned to demilitarized zone in 1993 Peaked in 2000 with 4100 cases Troops thought to be spreading to civilian populations Methods Targeted prophylaxis Radical cure before discharge 24
25 Not Spread Malaria - Examples Indonesian troops Overall in 2005 in Indonesia 10M cases 20K deaths Java and Bali 70% of 300M populations Nearly eliminated in 1964 Since resurged Elimination planned again Large numbers of troops 6 month rotations in highly malarious outer islands Will continuously reintroduce the diseases Solutions urgently needed 25
26 Not Spread Malaria - Solutions Effective diagnosis and treatment Consider ITN, IRS, Permethrin-treated treated uniforms Long-term prophylaxis Post-exposure radical cure Need Directly observed therapy Better diagnostic tools for carriers Pf and Pv antibody monitoring should be helpful New methods under development 26
27 Clinical Trials Malaria prophylaxis trials challenging Long-term prophylaxis Post-exposure/deployment p radical cure Asian militaries have been outstanding study populations Thai Indonesian Seek partners Sufficient malaria exposure Access for Directly Observed Therapy (DOT) 27
28 Example Clinical Trials 28
29 Example Clinical Trial Walsh et al. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. JID 2004 Taylor et al. Malaria prophylaxis using azithromycin a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. CID 1999 Ohrt et al. Mefloquine compared with doxycycline for the prophylaxis p of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine
30 Products Needing Evaluation Drugs for weekly prophylaxis Tafenoquine Malarone Chloroquine-azithromycin Other methods to prevent disease Impregnated uniforms Other mosquito prevention methods 30
31 Support of Elimination Operations Military strengths Planning Training Logistics Organization Human resource Technical expertise 31
32 Possible Application of Military Strengths Training Access to drugs, ITN, IRS/security Independent monitoring/security Above interventions Village health workers Drug quality (counterfeits, inappropriate regiments) Mass drug administration Border/migrant monitoring Resistance monitoring Ensure they are not transmitting the disease 32
33 Malaria Diagnostics Center of Excellence Train & certify microscopists Training materials External QA Assess new diagnostics 33
34 Possible Additional Benefits Multi-task training Mil-mil collaborative effort training Capacity building Mil-civilian rapport building Potential broader application Influenza Dengue Disaster response 34
35 DoD Global Malaria Research Program & Partners WRAIR & NMRC Washington, DC NAMRU-3 Cairo, Egypt Ghana AFRIMS Bangkok, Thailand, Cambodia, & Nepal AMI Brisbane, Australia USAMRU-Kenya NMRCD Lima, Peru NAMRU-2 Jakarta, Indonesia, Solomon Islands 35
36 ?? Questions Comments?? We seek Partnerships!! 36
Progress on the Containment of Artemisinin Tolerant Malaria Parasites in South-East Asia (ARCE) Initiative
Progress on the Containment of Artemisinin Tolerant Malaria Parasites in South-East Asia (ARCE) Initiative I. Background For many years, the border area between Cambodia and Thailand has been the source
More informationMalaria. Edwin J. Asturias, MD
Malaria Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public Health Global Health and Disasters Course
More informationAPPENDIX 1 DATA COLLECTION AND DISSEMINATION STEPS
APPENDIX 1 DATA COLLECTION AND DISSEMINATION STEPS 97 Country/ area APPENDIX 2a DRUG REGIMENS SEA REGION, 2001 (dosage for adults) : P. falciparum Lab confirmed Treatment failure Severe malaria Pregnancy
More informationEvidence Review Group on MDA, MSAT and FSAT Malaria Policy Advisory Committee Geneva, Switzerland September 2015
Evidence Review Group on MDA, MSAT and FSAT Malaria Policy Advisory Committee Geneva, Switzerland 16-18 September 2015 Kevin Marsh Chairperson of the Evidence Review Group 1 Outline of the Presentation
More informationInterpretation of the World Malaria Report Country Profile
Interpretation of the World Malaria Report Country Profile Acknowledgements This presentation was developed to help explain the components of the World Malaria Report Country Profile. The 2017 World Malaria
More informationPreparing for the Next Global Threat A Call for Targeted, Decisive Action Now to Prevent The Next Pandemic
Preparing for the Next Global Threat A Call for Targeted, Decisive Action Now to Prevent The Next Pandemic Colin Ohrt, MD, MPH Founding Director, Consortium for Health Action Minnesota, USA; Hanoi, Vietnam;
More informationSlides courtesy of: COL (Ret) Kent Kester COL James Cummings UNCLASSIFIED / FOUO
Malaria M A J K r i s P a o l i n o, M D I n f e c t i o u s D i s e a s e S t a f f C h i e f, C l i n i c a l T r i a l s C e n t e r W a l t e r R e e d A r m y I n s t i t u t e o f R e s e a r c h
More informationResuming the fight against relapse of Plasmodium vivax
Resuming the fight against relapse of Plasmodium vivax Professor J. Kevin Baird Head of Unit, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia & Centre for Tropical Medicine Nuffield Department
More informationBefore the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights. December 5, 2011
Written Testimony of Dr. Dennis Schmatz President of the USA Board of Medicines for Malaria Venture and Chair of MMV s Expert Scientific Advisory Committee Before the House Foreign Affairs Subcommittee
More informationSummary World Malaria Report 2010
Summary The summarizes information received from 106 malaria-endemic countries and other partners and updates the analyses presented in the 2009 Report. It highlights continued progress made towards meeting
More informationScenario#1 Fever from Kenya. New Drugs for Malaria
New Drugs for Malaria This talk may be politically incorrect or in bad 1 taste.viewer discretion is advised 2 Scenario#1 Fever from Kenya A 37 year old traveller returns from a one month vacation in rural
More informationStrategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030
Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030 Dr Walter M Kazadi Coordinator Regional Hub Emergency Response to Artemisinin Resistance Regional Hub GMS MMV
More informationAnti-Malaria Chemotherapy
Anti-Malaria Chemotherapy Causal Prophylaxis prevent infection (ie, liver stage) Suppressive Prophylaxis prevent clinical disease (ie, blood stages) Treatment Therapy (or clinical cure) relieve symptoms
More informationAgainst intervention No recommendation Strong Conditional Conditional Strong. For intervention. High Moderate Low Very low
Draft recommendation: Consider using MDA as an additional tool for the elimination of malaria in low prevalence island or nonisland settings where the risk of imported malaria is low Balance of desirable
More informationEighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries
Summary report on the Eighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries WHO-EM/MAL/384/E Islamabad, Pakistan 12 14 December 2016 Summary report on the
More informationFighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010
Fighting Harder and Smarter Against Malaria Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010 Outline Burden of malaria Global support for rolling back malaria
More informationSymptoms of Malaria. Young children, pregnant women, immunosuppressed and elderly travellers are particularly at risk of severe malaria.
Preventing Malaria 1 Malaria is the world s most prevalent parasitic disease, accounting for an estimated 216 million cases with 655,000 deaths annually. Many people acquire malaria during travel to tropical
More informationFrom a one-size-fits-all to a tailored approach for malaria control
From a one-size-fits-all to a tailored approach for malaria control MMV 12 th Stakeholders Meeting New Delhi, India 07 November 2012 Robert D. Newman, MD, MPH Director, Global Malaria Programme newmanr@who.int
More informationDirectorate of National Vector Borne Disease Control Programme
NATIONAL DRUG POLICY ON MALARIA (2008) Directorate of National Vector Borne Disease Control Programme (Directorate General of Health Services) Ministry of Health and Family Welfare 22-Shamnath Marg,, Delhi-110054..
More informationDisclosure Information
Malaria Medications Charlie Mosler, RPh, PharmD, CGP, FASCP Assistant Professor of Pharmacy Practice The University of Findlay College of Pharmacy Findlay, OH mosler@findlay.edu Disclosure Information
More informationCombination Anti-malarial Therapy and WHO Recommendations
Prakaykaew Charunwatthana 2, and Sasithon Pukrittayakamee 1,2 1 Associate Fellow of the Royal Institute, Academy of Science 2 Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol
More informationMalaria. COL Ted Cieslak MD FAAP FIDSA. Select SLIDE MASTER to Insert Briefing Title Here. 25-Sep-14
Malaria COL Ted Cieslak MD FAAP FIDSA Worldwide Human Deaths By Cause Millions of Deaths 0 5 10 15 20 Infectious & Parasitic Cardiovascular Cancer Injury Perinatal &Neonatal Chronic Pulmonary Maternal
More informationMalaria Elimination: Future Reality?
Malaria Elimination: Future Reality? Global Health Mini University March 4, 2016 Outline Highlight tremendous progress recorded in malaria control Discuss key challenges to further progress Highlight new
More informationCopenhagen, Denmark, September August Malaria
Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support
More informationDisclaimer UNCLASSIFIED / FOUO
A Bad Thing to Get Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department of Army, Department of Defense, or U.S. Government
More informationAntimalarial drug resistance
Antimalarial drug resistance Md Mushfiqur Rahman*, Leonard Ortega**, R M Rastogi* and Krongthong Thimasarn* Abstract Antimalarial drug resistance is of great concern in the WHO South-East Asia (SEA) Region.
More informationAntimalarial Drugs. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014
Antimalarial Drugs Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014 Malaria Annual Global Incidence: 219 million in 2010. Annually, in Africa, I million children
More information26/06/ NIMR 2018 Conference - Malaria - a reality
Malaria Elimination: Reality or Myth? Wellington A. Oyibo ANDI CENTRE OF EXCELLENCE FOR MALARIA DIAGNOSIS WHO/FIND Malaria Specimen Collection Site The International Center for Malaria Microscopy and Malaria
More informationMD, FACP, FIDSA, FRGS
Malaria COL James F. Cummings, MD, FACP, FIDSA, FRGS Director, Global Emerging Infections Surveillance and Response System (GEIS) Armed Forces Health Surveillance Center (AFHSC) Consultant to the US Army
More informationASIA PACIFIC MALARIA GUIDE A QUICK REFERENCE FOR JOURNALISTS AND OTHERS INTERESTED IN MALARIA AND ITS ELIMINATION IN THE ASIA PACIFIC
ASIA PACIFIC MALARIA GUIDE A QUICK REFERENCE FOR JOURNALISTS AND OTHERS INTERESTED IN MALARIA AND ITS ELIMINATION IN THE ASIA PACIFIC ACRONYMS AND ABBREVIATIONS ACT APLMA APMEN bn CDC DDT DOT FDA GHG IPT
More informationHow to protect yourself against malaria
World Health Organization 17 September, 2008 How to protect yourself against malaria Mine Action Technology Workshop 2008 co-hosted by the United Nations Mine Action Service (UNMAS) and the Geneva International
More informationImported malaria: a possible threat to the elimination of malaria from Sri Lanka?
Tropical Medicine and International Health doi:0./tmi.097 volume 8 no 6 pp 76 768 june 03 Imported malaria: a possible threat to the elimination of malaria from Sri Lanka? G. N. L. Galappaththy, S. D.
More informationMalaria parasites Malaria parasites are micro-organisms that belong to the genus Plasmodium. There are more than 100 species of Plasmodium, which can infect many animal species such as reptiles, birds,
More informationDriving access to medicine
Driving access to medicine An example from the Novartis Malaria Initiative Hans Rietveld Director, Market Access & Capacity Building Novartis Malaria Initiative Social Forum - Geneva February 20, 2015
More informationMalaria. WRAIR- GEIS 'Operational Clinical Infectious Disease' Course
Malaria WRAIR- GEIS 'Operational Clinical Infectious Disease' Course Acknowledgments COL Pete Weina, MD, PhD Chief, Department of Research Programs Walter Reed National Military Medical Center COL Arthur
More information128th Session 25 November 2010 Provisional agenda item Malaria. Prevention and control: sustaining the gains and reducing transmission
EXECUTIVE BOARD 128th Session 25 November 2010 Provisional agenda item 4.11 Malaria Prevention and control: sustaining the gains and reducing transmission Report by the Secretariat 1. Millennium Development
More informationRegional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries
Summary report on the Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries Casablanca, Morocco 18 20 October
More informationMedia centre Malaria. Key facts. Symptoms
Media centre Malaria Fact sheet Updated November 2017 Key facts Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes.
More informationAssessing Seroprevalence of Dengue Fever in US Army Special Operations Forces
Assessing Seroprevalence of Dengue Fever in US Army Special Operations Forces LTC Jennifer Caci USASOC ESO GMCA 2009 Acknowledgements USASOC Surgeon s Office LTC Art Lyons, WRAIR MAJ Danielle Tack, 98
More informationRepellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd
The Jojoo Mosquito Repellent Soap Africa s innovative solution to Malaria prevention Sapphire Trading Company Ltd P.O.Box: 45938-00100 Nairobi, Kenya. Tel: +254 735 397 267 +254 733 540 868 +254 700 550
More informationImplementing the Abuja Declaration and Plan of Action: the journey so far
Implementing the Abuja Declaration and Plan of Action: the journey so far The Abuja Declaration African leaders who met on 25 April 2000 in Abuja, Nigeria, laid out the foundation for a sustained battle
More informationAntimalarials in the WHO Essential Drugs List for Children Reviewer No.1
Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Part I: Evaluation of the current list Proposed grouping from the March 2007 meeting 6.5.3 Antimalarial medicines 6.5.3.1 For curative
More informationPreparing for the Next Global Threat A Call for Targeted, Decisive Action Now to Prevent The Next Pandemic
Preparing for the Next Global Threat A Call for Targeted, Decisive Action Now to Prevent The Next Pandemic Colin Ohrt, MD, MPH Founding Director, Consortium for Health Action Minnesota, USA; Hanoi, Vietnam;
More informationWHO Global Malaria Programme. February 2009
WHO Global Malaria Programme February 2009 Table of Contents 1. The world malaria situation 2. The critical role of WHO's Global Malaria Programme 3. Our programme of work explained 4. Situation analysis
More informationSummary of the Ninth Meeting of the ITFDE (II) May 12, 2006 (revised)
Summary of the Ninth Meeting of the ITFDE (II) May 12, 2006 (revised) The Ninth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 9:00am to
More informationA New Class of Malaria Drugs: The Coartem Breakthrough from Novartis
A New Class of Malaria Drugs: The Coartem Breakthrough from Novartis and its Chinese Partners Hans Rietveld, Director, Global Access and Marketing, Malaria Initiative, Novartis Pharma AG Workshop on Access
More informationRajitha Wickremasinghe Professor of Public Health University of Kelaniya Sri Lanka UNIVERSITY OF KELANIYA
Rajitha Wickremasinghe Professor of Public Health University of Kelaniya Sri Lanka Sri Lanka 250,000 200,000 150,000 100,000 50,000 0 80 70 60 50 40 30 20 10 0 Total Cases (Cases - Imported) Deaths (Secondary
More informationRisk of malaria in Travelers
Malaria Prevention & Chemoprophylaxis Risk of malaria in Travelers Watcharapong Piyaphanee MD, Board Int Med, CTH, Dip Trav Med, MFTM RCPS (Glasgow) Travel Medicine Research Unit Faculty of Tropical Medicine,
More informationU.S. Response to the Global Threat of Malaria: Basic Facts
U.S. Response to the Global Threat of Malaria: Basic Facts Alexandra E. Kendall Analyst in Global Health June 15, 2012 CRS Report for Congress Prepared for Members and Committees of Congress Congressional
More informationThe Current Status of the Epidemiologic Transition
The Current Status of the Epidemiologic Transition There are still job opportunities in Infectious Diseases and Tropical Medicine CAPT John W. Sanders, Medical Corps, US Navy Commanding Officer, Naval
More informationThe Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Watersheds of the African Continent
The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale Global Risk By Country-Proportionality Plot P. falciparum P. vivax Distribution of Plasmodium falciparum 3 million
More informationThe Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Distribution of Plasmodium falciparum
The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale Distribution of Plasmodium falciparum 1 Distribution Of Plasmodium vivax 2 Global Risk By Country-Proportionality
More informationNOTABLE EVENTS IN NATIONAL POLICY AND FINANCING FOR MALARIA
Malaria Policy Landscape PATH MACEPA JULY 2016 OVERVIEW API 2014 PATH MACEPA has been working in partnership with s Federal Ministry of Health (FMOH) since 2007 and the Amhara Regional Health Bureau (ARHB)
More informationSwaziland National Malaria Elimination Policy
DRAFT 21 April 2010 Swaziland National Malaria Elimination Policy Version 1.0 May 2010 Kingdom of Swaziland Ministry of Health National Malaria Control Programme TABLE OF CONTENTS Acronyms... 3 Foreword...
More informationINDONESIA COUNTRY PRESENTATION
INDONESIA COUNTRY PRESENTATION Non Endemic Low Endemic Moderate Endemic High Endemic Out of Indonesia. ANNUAL PARASITE INCIDENCE (API o/oo) JAVA BALI, 1989-2002 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 1989
More informationNATIONAL MALARIA ELIMINATION ACTION PLAN Ministry of Health Belize
NATIONAL MALARIA ELIMINATION ACTION PLAN 2015-2020 Ministry of Health Belize October, 2015 Table of Content Contextual Analysis 1 Situation Analysis of Malaria in Belize 2 Malaria Program in Belize 3 Vision
More informationAchieving Consensus on Malaria Recommendations: Is It Possible? Mary E. Wilson, MD May 28, 2015 CISTM14 Québec City, Canada
Achieving Consensus on Malaria Recommendations: Is It Possible? Mary E. Wilson, MD May 28, 2015 CISTM14 Québec City, Canada I have no conflicts of interest to disclose. 2 Questions How do guidelines/recommendations
More information1. The World Bank-GAVI Partnership and the Purpose of the Review
1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationMass drug Administration When Is It Useful
Mass drug Administration When Is It Useful Kwaku Poku Asante, MD MPH PhD Kintampo Health Research Centre, Ghana Malaria Control and Elimination 8-9 December 2016, Congress Center Basel, Switzerland MDA
More informationPURPOSE The purpose of the Malaria Control Strategic Plan 2005/ /10 is to provide a common platform and detailed description of interventions
PURPOSE The purpose of the Malaria Control Strategic Plan 2005/06-2009/10 is to provide a common platform and detailed description of interventions for all RBM partners and sectors of society. It encourages
More informationMalaria Symposia Myanmar Medical Association. Dr Aung Thi National Malaria Control Program 04 March 2017
Malaria Symposia Myanmar Medical Association Dr Aung Thi National Malaria Control Program 04 March 2017 OUTLINE OF THE PRESENTATION Country profile Programmatic achievements Challenges Lessons learnt Way
More informationM A L A R I A. The Burden of Malaria: The Impact and Cost of Malaria:
M A L A R I A The world is at a potential turning point in the fight against malaria. We are better placed than ever before to scale up efforts using existing tools and proven solutions to tackle malaria.
More informationThe PATH Innovation Pipeline for Malaria
path malaria learning series The PATH Innovation Pipeline for Malaria Transformative tools and approaches for defeating malaria Making progress against malaria requires collaboration across borders, sectors,
More informationFact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM
Fact sheet Poliomyelitis WHO Media centre ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM Media centre Poliomyelitis Fact sheet Updated April 2016 Key
More informationEXECUTIVE SUMMARY THE PRESIDENT S MALARIA INITIATIVE
EXECUTIVE SUMMARY THE PRESIDENT S MALARIA INITIATIVE Ninth Annual Report to Congress April 2015 EXECUTIVE SUMMARY Maggie Hallahan Photography The fight against malaria is making historic gains across sub-saharan
More informationPathogen Surveillance Program. DoD Global Respiratory. USAF School of Aerospace Medicine & Defense Health Agency
DoD Global Respiratory Pathogen Surveillance Program USAF School of Aerospace Medicine & 2017-2018 Defense Health Agency Cumulative Results Locations 97 Collected 11,124 Tested 11,002 Influenza A 2,594
More informationLANTOS-HYDE UNITED STATES GOVERNMENT MALARIA STRATEGY
DEBBIE GUEYE/PMI ABT ASSOCIATES LANTOS-HYDE UNITED STATES GOVERNMENT MALARIA STRATEGY 2009 2014 SIMPLICE TAKOUBO/PMI ARTURO SANABRIA/PHOTOSHARE APRIL 25, 2010 PRESIDENT S MALARIA INITIATIVE Report Documentation
More informationRAM Conference Australian Army Malaria Institute Gallipoli Barracks Enoggera Qld
RAM Conference 2012 Australian Army Malaria Institute Gallipoli Barracks Enoggera Qld The official welcome was extended to delegates by Professor Dennis Shanks on behalf of the Army Malaria Institute.
More informationRoadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap
Background to development of vaccine roadmaps, to include priority areas for research, product development, capacities, and policy and commercialization Roadmaps as a Vehicle for Addressing Large- Scale
More informationKato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1
Kato, N. et al, Nature, 2016, Accelerated Article Preview Celeste Alverez Current Literature 9/10/2016 9/10/2016 Celeste Alverez @ Wipf Group 1 Malaria Caused by Plasmodium parasites Carried by 30-40 species
More informationMALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY
MALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY Calvin L. Wilson MD Clinical Professor of Family Medicine and Public Health University of Colorado Anschutz OBJECTIVES 1. Understand the unique characteristics
More informationThe Training Partnership of the Inter-Agency Working Group (IAWG) on Reproductive Health in Crisis Situations
1 Strategy Paper for Donor Agencies The Training Partnership of the Inter-Agency Working Group (IAWG) on Reproductive Health in Crisis Situations At a glance: Why Reproductive Health matters in crisis
More informationInvest in the future, defeat malaria
Invest in the future, defeat malaria Malaria is caused by parasites from the genus Plasmodium, which are spread to people by infected mosquitoes. There are five species of Plasmodium that can infect humans.
More informationArtesunate Mefloquine (AsMq)
Artesunate Mefloquine (AsMq) Introduction AsMq in Rakhine in 1996 AsMq FDC compared to other ACTs AZG (MSF-Holland) malaria activities in Western Myanmar 9 townships 25 DoH clinics with AZG support (area
More informationEnding Malaria in Nigeria: The WHO Agenda
Nigeria Institute of Medical Research 2016 World Malaria Day Lecture 27 April, 2016 Ending Malaria in Nigeria: The WHO Agenda Dr Tolu Arowolo Malaria Containment Programme, WHO, Nigeria arowolot@who.int
More informationSupporting Accelerate to Zero: The BMGF Malaria Vector Control
Supporting Accelerate to Zero: The BMGF Malaria Vector Control Research Agenda NCAR-CDC Climate and Health Workshop Boulder CO 14 Jul 2015 Mike Reddy PhD MPH Dan Strickman MS PhD Malaria, (Prevent Transmission
More informationL3-Malaria: Epidemiology, clinical management and control. 19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS
19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS L3-Malaria: Epidemiology, clinical management and control Lecturer: Niwat Kangwanrangsan, Ph.D. Department of Pathobiology Faculty of Science,
More informationPARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia)
PARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia) A 37-year-old woman, who had traveled to New Guinea for several weeks, presented to the medical clinic with fever, chills, and rigors within
More informationGlobal Report on Antimalarial Drug. and the Global Plan for Artemisinin Resistance Containment (GPARC)
Global Report on Antimalarial Drug Resistance and Drug Efficacy: 2-21 21 and the Global Plan for Artemisinin Resistance Containment (GPARC) MMV Stakeholders Meeting Dar es Salaam, Tanzania 2 June 211 Robert
More information38 Current Concepts in
38 Current Concepts in Management of Falciparum Malaria Abstract: Artemisinin based Combination Therapy (ACT) is the preferred agent to treat drug resistance uncomplicated Plasmodium Falciparum (PF) Malaria.
More informationCost-Effectiveness Analysis of Chemoprophylaxis of Malaria Treatment
Kim EJ. Cost-Effectiveness Analysis of Chemoprophylaxis of Malaria Treatment. J Infectiology. 2018; 1(1): 11-15 Research Article Journal of Infectiology Open Access Cost-Effectiveness Analysis of Chemoprophylaxis
More informationSummary of the Eighth Meeting of the ITFDE (II) October 4, 2005
Summary of the Eighth Meeting of the ITFDE (II) October 4, 2005 The Eighth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 9:00am to 4:00pm
More informationMalaria Control. Umberto D Alessandro
Malaria Control Umberto D Alessandro Zanzibar - hospitalizations et malaria deaths 1999-2008 2 The Gambia - slide positivity rates 2003-2009 Under-5 mortality rate (per 1,000 live births) 300 250 200 150
More informationStudy Plan: Screening
Phase 1 with Sporozoite Challenge Open-Label Dose-Escalation Safety, Reactogenicity, Immunogenicity, and Efficacy of the Vaccine Candidate Plasmodium falciparum Malaria Protein (FMP012), an E coli-expressed
More informationDisease Narrative for Malaria and Areas for Intervention
Disease Narrative for Malaria and Areas for Intervention ADAPTED FROM CONTENT DEVELOPED FOR PRESENTATION TO UNITAID EXECUTIVE BOARD FOR ITS 23 MEETING (11/2015) Executive Summary In the past 15 years,
More informationEconomic and Social Council
United Nations E/CN.6/2010/L.6 Economic and Social Council Distr.: Limited 9 March 2010 Original: English ADOPTED 12 March 2010 ADVANCE UNEDITED VERSION Commission on the Status of Women Fifty-fourth session
More informationMefloquine Is Highly Efficacious against Chloroquine-Resistant Plasmodium vivax Malaria and Plasmodium falciparum Malaria in Papua, Indonesia
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Navy Research U.S. Department of Defense 2006 Mefloquine Is Highly Efficacious against Chloroquine-Resistant Plasmodium
More informationOF ANTIMALARIAL DRUGS
THE USE OF ANTIMALARIAL DRUGS THE USE OF ANTIMALARIAL DRUGS Report of an Informal Consultation World Health Organization, Geneva WHO, 2001 Technical Review: A. Bosman, C. Delacollette, P. Olumese, R. G.
More informationMILITARY PREVENTIVE MEDICINE: MOBILIZATION AND DEPLOYMENT Volume 2
MILITARY PREVENTIVE MEDICINE: MOBILIZATION AND DEPLOYMENT Volume 2 Section 6: Infectious Diseases of Concern Franklin Boggs Pill Call Soldiers in the South Pacific theater during World War II get their
More informationMinutes of the Drug Resistance and Containment Technical Expert Group
Minutes of the Drug Resistance and Containment Technical Expert Group 28 30 April 2014 Starling Hotel, Geneva, Switzerland Contents Acknowledgments... 3 Abbreviations... 4 Summary and recommendations...
More informationMalaria: Prevention remains our best measure for controlling the disease
http://www.medicine-on-line.com Malaria: 1/10 Malaria: Prevention remains our best measure for controlling the disease Author: Supervisor: Affiliation: Naomi Cheng Professor Julia Ling The Chinese University
More information54% WHO s emergency response to artemisinin resistance SHARP DECLINE IN MALARIA CASES AND DEATHS SEEN ACROSS THE GMS BULLETIN #5 SEPTEMBER 2016
BULLETIN #5 WHO s emergency response to artemisinin resistance SEPTEMBER 2016 SHARP DECLINE IN MALARIA CASES AND DEATHS SEEN ACROSS THE GMS 54% REDUCTION IN MALARIA CASES OVER 3 YEARS Increased access
More informationPandemic Influenza Preparedness and Response
24 th Meeting of Ministers of Health Dhaka, Bangladesh, 20-21 August 2006 SEA/HMM/Meet.24/4(b) 10 July 2006 Pandemic Influenza Preparedness and Response Regional situation: Human cases and outbreaks of
More informationMalaria: A Global Perspective and Prospects for Elimination. Rima Shretta
Malaria: A Global Perspective and Prospects for Elimination Rima Shretta Background Spread by the female anopheles mosquito; caused by plasmodium parasite: P. falciparum, P. vivax, P. ovale, P. malariae,
More informationThe Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
More informationMalaria prevention: source = The Sanford Guide to Antimicrobial Therapy. Gilbert et al.
Malaria prevention: Agent Adult dose a Contraindications Application Notes Atovaquoneproguanil 250/100mg x1/day Insufficient data in pregnancy Prophylaxis for areas with CQ resistance, 2 expensive with
More informationINVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA
Photo by Dominic Chavez INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA Private Sector Engagement in the Global Financing Facility in Support of Every Woman Every Child 1 www.globalfinancingfacility.org
More informationTitle: Author: Benji Mathews. Date: 1/4/08. Key words: Malaria, Travel, Medications
Title: Author: Benji Mathews Date: 1/4/08 Key words: Malaria, Travel, Medications Abstract: Malaria is an insect borne disease widespread in tropical and subtropical regions of the world. It causes about
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More information